| Literature DB >> 28068897 |
Anna Kur-Piotrowska1, Marta Kopcewicz1, Leslie P Kozak1, Pawel Sachadyn2, Anna Grabowska1, Barbara Gawronska-Kozak3.
Abstract
BACKGROUND: Mouse fetuses up to 16 day of embryonic development and nude (Foxn1- deficient) mice are examples of animals that undergo regenerative (scar-free) skin healing. The expression of transcription factor Foxn1 in the epidermis of mouse fetuses begins at embryonic day 16.5 which coincides with the transition point from scar-free to scar-forming skin wound healing. In the present study, we tested the hypothesis that Foxn1 expression in the skin is an essential condition to establish the adult skin phenotype and that Foxn1 inactivity in nude mice keeps skin in the immature stage resembling the phenomena of neoteny.Entities:
Keywords: Mmp-9; Next-generation sequencing; Regeneration; Transcriptome
Mesh:
Substances:
Year: 2017 PMID: 28068897 PMCID: PMC5223329 DOI: 10.1186/s12864-016-3401-z
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Comparison of the numbers of genes differentially regulated in skin (a) and epidermis (b). Genes that are up- and down-regulated in common for nude and E14 (c). B6 (C57BL/6J; 6 weeks old), nude (B6.Cg-Foxn1 nu; 6 weeks old), E14 (C57BL/6J; 14 day of embryonic development) and E18 (C57BL/6J; 18 day of embryonic development). Numbers next to arrows specify the number of genes that are differentially expressed (using a cutoff threshold of 2-fold difference). Length of arrows indicates the relative abundance of differently regulated genes between groups (a) and (b). The analysis was performed as an overlay of gene lists from two tested sets of genes: nude vs B6 and E14 vs E18 (c)
Selected genes enriched in differentially expressed transcripts nude and E14 skin and relevant functional categories. For epidermis the analysis relays on the comparison of genes differently regulated between nude and B6
| Functional categories and representative genes | Skin | Epidermis | ||||
|---|---|---|---|---|---|---|
| E14 | nude | nude | ||||
| up ( | down ( | up ( | down ( | up ( | down ( | |
| Tissue remodeling | ||||||
| Zymogen | × (1.2 × 10−8) | × (4.5 × 10−9) | ||||
| Endopeptidase activity | × (7.1 × 10−2) | × (9.3 × 10−2) | ||||
| Metallopeptidase | × (2.3 × 10−2) | × (2.4 × 10−3) | ||||
| Protease | × (5.0 × 10−5) | × (1.5 × 10−6) | ||||
|
| 10.66 | 63.36 | 2.61 | |||
|
| 11.14 | 10.95 | 2.15 | |||
|
| 3.22 | 4.26 | ||||
|
| 8.68 | 29.83 | 5.19 | |||
| Cytoskeletal rearrangments | ||||||
| Keratinization | × (3.8 × 10−2) | × (8.9 × 10−4) | × (4.9 × 10−2) | |||
| Keratin | × (3.2 × 10−8) | |||||
| Cornified envelope | × (4.6 × 10−5) | × (3.9 × 10−7) | × (1.6 × 10−8) | |||
| Keratinocyte differentiation | × (1.5 × 10−2) | × (1.8 × 10−4) | × (1.9 × 10−4) | |||
|
| 12.06 | 7.86 | ||||
|
| 8.35 | 17.89 | 3.85 | |||
|
| 2.8 | 3.25 | 2.2 | |||
|
| 9.14 | 27.58 | 2.61 | |||
|
| 13.3 | 33.43 | 3.69 | |||
|
| 15.66 | 12.88 | 4.71 | |||
|
| 21.31 | |||||
|
| 4.65 | 34.82 | 3.85 | |||
|
| 14.62 | 6.9 | 4.45 | |||
| Wound healing and immune response | ||||||
| Inflammatory response | × (1.8 × 10−7) | × (8.3 × 10−13) | × (2.8 × 10−2) | |||
| Chemokine activity | × (1.7 × 10−5) | × (6.2 × 10−6) | × (8.6 × 10−2) | |||
| Positive regulation of T cell differentiation | × (5.2 × 10−3) | × (1.9 × 10−2) | ||||
|
| 2.49 | 2.77 | ||||
|
| 7.47 | 5.07 | ||||
|
| 6.32 | 7.75 | ||||
|
| 13.67 | 12.27 | 4.34 | |||
|
| 9.67 | 10.45 | 4.15 | |||
|
| 2.5 | 3.14 | ||||
| Differentiation | ||||||
| Differentiation | × (2.3 × 10−4) | × (1.6 × 10−4) | × (1.5 × 10−3) | |||
| Developmental protein | × (5.8 × 10−11) | × (3.0 × 10−17) | × (2.8 × 10−2) | |||
|
| 4.47 | 4.32 | ||||
|
| 18.2 | 7.65 | ||||
|
| 4.08 | 2.41 | ||||
|
| 5.83 | 3.7 | ||||
|
| 3.66 | 9.66 | ||||
|
| 6.33 | 5.39 | ||||
|
| 8.94 | 9.47 | ||||
|
| 7.11 | 9.39 | ||||
|
| 6.57 | 7.34 | ||||
|
| 4.07 | 8.29 | ||||
|
| 15.18 | 10.96 | ||||
Selected group of genes characteristic for nude mice
| Gene | Gene name | Epidermis | Skin | ||
|---|---|---|---|---|---|
| nude vs B6 | nude vs B6 | ||||
| up | down | up | down | ||
|
| WNT1 inducible signaling pathway protein 2 | 13.46 | |||
|
| Wingless related MMTV integration site 10a | 4.64 | |||
|
| Wingless-related MMTV integration site 11 | 3.38 | 2.48 | ||
|
| Wingless-related MMTV integration site 7A | 5.63 | |||
|
| Frizzled homolog 1 (Drosophila) | 2.18 | |||
|
| Frizzled homolog 6 (Drosophila) | 2.02 | |||
|
| Frizzled-related protein | 5.08 | |||
|
| Secreted frizzled-related protein 2 | 2.38 | |||
|
| Catenin (cadherin associated protein), beta 1 | 4.9 | |||
|
| Catenin, beta like 1 | 2.26 | |||
|
| Dickkopf homolog 1 (Xenopus laevis) | 8.22 | |||
|
| Delta-like 1 homolog (Drosophila) | 9.01 | |||
|
| Dll-4 mRNA for Delta-4 | 3.18 | |||
|
| Delta-like 1 (Drosophila) | 2.7 | 2.33 | ||
|
| Notch2 | 2.36 | |||
|
| Notch gene homolog 4 (Drosophila) | 2.48 | |||
|
| Hairy and enhancer of split 5 (Drosophila) | 10.26 | |||
|
| Hairy and enhancer of split 6 (Drosophila) | 8.41 | |||
|
| Brain cDNA, clone MNCb-2686, similar to Mus musculus hairy/enhancer-of-split related with YRPW motif1 | 3.39 | |||
|
| HES-related repressor protein 1 HERP1 | 2.39 | |||
|
| Bone morphogenetic protein 2 | 2.4 | 3.55 | ||
|
| Bone morphogenetic protein 4 | 3.23 | |||
|
| Bone morphogenetic protein receptor, type 1B | 2.75 | |||
|
| MAD homolog 1 (Drosophila) | 2.56 | |||
|
| Matrix metallopeptidase 12 | 3.89 | 64.36 | ||
|
| Matrix metallopeptidase 3 | 21.83 | |||
|
| Matrix metallopeptidase 13 | 5.46 | |||
|
| Matrix metallopeptidase 8 | 4.71 | |||
|
| Tissue inhibitor of metalloproteinase 1 | 3.58 | |||
|
| Matrix metallopeptidase 9 | 2.22 | 3.28 | ||
|
| Matrix metallopeptidase 2 | 2.21 | 3.02 | ||
aGenes that are down regulated in E14 skin (see Table S2)
Fig. 2Validation of sequencing data by qRT-PCR for Foxn1 (a), Mmp-13 (b) and Mmp-9 (c). Histological (d-g), immunohistochemical (h-o) analyses of skin tissues from E14 (d, h, l), E18 (e, i, m), nude (f, j, n) and B6 (g, k, o) skin. Hematoxylin and eosin stained sections (d-g), and immunohistochemical detection of Mmp-9 protein expression (h-o). Figure l-o are the higher magnifications of figures h-k. Arrows indicate positive reaction for Mmp-9 in epidermis: E14 (h, l) and B6 (k, o); dermis: E18 (i, m) and subcutenous tissues in nude (j, n). Immunohistochemical sections (h-o) were counterstained with hematoxylin. E - epidermis. Scale bar = 50 μm (d-j), 100 μm (k), 20 μm (l-o)
Fig. 3Involucrin protein expression in nude, B6, E14 and E18 skin samples. Representative Western Blots (a), densitometric analysis (b) and immunodetection (c-f) of involucrin protein expression in E14 (c), E18 (d), nude (e), B6 (f) skin samples. Arrows indicate positive reaction for involucrin (c-f). Immunohistochemical sections (e-f) were counterstained with hematoxylin. E – epidermis, HF – hair follicles. Scale bar = 20 μm
Fig. 4In vitro analysis of Fgf2 effects on Mmp-13 (a), Mmp-3 (b), Mmp-9 (c, e) and Mmp-2 (d) expression in dermal fibroblasts from nude and B6 mice. Quantitative RT-PCR for Mmp-13 (a), Mmp-3 (b), Mmp-9 (c) and Mmp-2 (d) mRNA expression and Western blot for Mmp-9 (e) protein are presented